Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.895
-0.021 (-2.24%)
Nov 21, 2024, 1:29 PM EST - Market open
Cytosorbents Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -18.67 | -28.51 | -32.81 | -24.56 | -7.84 | -19.27 | Upgrade
|
| Depreciation & Amortization | 2.11 | 2.03 | 1.13 | 1.13 | 0.66 | 0.58 | Upgrade
|
| Other Amortization | 0.19 | - | - | - | 0.32 | 0.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.13 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.49 | 0.66 | 0.64 | - | - | - | Upgrade
|
| Stock-Based Compensation | 3.3 | 3.7 | 3.8 | 6.2 | 4.71 | 2.84 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.11 | 0.01 | -0.01 | -0 | -0.1 | 0.07 | Upgrade
|
| Other Operating Activities | -3.24 | -1.91 | 2.45 | 2.58 | -2.61 | 0.35 | Upgrade
|
| Change in Accounts Receivable | -0.27 | -0.25 | -1.29 | 0.42 | -0.33 | -0.64 | Upgrade
|
| Change in Inventory | -0.16 | -0.12 | 0.95 | -2.35 | -0.46 | -1.28 | Upgrade
|
| Change in Accounts Payable | -2.59 | 1.62 | -3.25 | 2.43 | 1.11 | 1.42 | Upgrade
|
| Change in Other Net Operating Assets | 0.24 | 1.1 | 0.03 | 0.15 | -1.08 | -0.95 | Upgrade
|
| Operating Cash Flow | -18.49 | -21.66 | -28.23 | -14.01 | -5.61 | -16.76 | Upgrade
|
| Capital Expenditures | -0.31 | -0.54 | -6.09 | -3.64 | -0.71 | -0.7 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.37 | -0.4 | -0.37 | -0.64 | -0.97 | -0.82 | Upgrade
|
| Investing Cash Flow | -0.68 | -0.94 | -6.46 | -4.28 | -1.68 | -1.52 | Upgrade
|
| Long-Term Debt Issued | - | - | 5 | - | 1.41 | 5 | Upgrade
|
| Total Debt Issued | 15 | - | 5 | - | 1.41 | 5 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -16.41 | - | Upgrade
|
| Net Debt Issued (Repaid) | 10 | - | 5 | - | -15 | 5 | Upgrade
|
| Issuance of Common Stock | 12.22 | 14.47 | - | 0.81 | 81.72 | 3.18 | Upgrade
|
| Other Financing Activities | -0.85 | - | -0.04 | -0.09 | -0.38 | -0 | Upgrade
|
| Financing Cash Flow | 21.37 | 14.47 | 4.96 | 0.72 | 66.35 | 8.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.08 | -0.1 | -0.26 | -0.02 | 0.13 | -0.04 | Upgrade
|
| Net Cash Flow | 2.12 | -8.22 | -29.99 | -17.6 | 59.19 | -10.14 | Upgrade
|
| Free Cash Flow | -18.8 | -22.19 | -34.32 | -17.65 | -6.32 | -17.46 | Upgrade
|
| Free Cash Flow Margin | -49.82% | -61.06% | -98.94% | -40.88% | -15.42% | -69.97% | Upgrade
|
| Free Cash Flow Per Share | -0.36 | -0.50 | -0.79 | -0.41 | -0.16 | -0.54 | Upgrade
|
| Cash Interest Paid | 0.87 | 0.38 | - | - | 1.13 | 1.06 | Upgrade
|
| Levered Free Cash Flow | -11.95 | -12.12 | -23.8 | -8.88 | -3.72 | -11.29 | Upgrade
|
| Unlevered Free Cash Flow | -11.62 | -12.02 | -23.8 | -8.88 | -3.29 | -10.76 | Upgrade
|
| Change in Net Working Capital | 3.03 | -2.11 | 2.97 | -2.28 | 0.5 | 0.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.